What's Next for Cremascoli Ortho?
One of the few mid-sized European orthopedic companies to build a continental presence, Cremascoli has been extremely successful. But now it contemplates its future in an industry driven by consolidation.
You may also be interested in...
Long a pioneer in prosthetics, one of orthopedics' forgotten spaces, Stanmore Implants Worldwide, has a new investor group who hope to transform this once academic supplier into a thriving orthopedics player by focusing on specialty niches that the Ortho giants have largely ignored.
Federal law requiring agencies to weigh and document potential environmental impacts of major regulatory actions does not dictate what happens next. Neither does it provide federal agencies with authorities beyond their statutory purviews, FDA/CDER leadership says.